biobucks

Merck hands over $20M in IBD target deal with Quotient

After generating interest from Pfizer and GSK, Quotient Therapeutics’ somatic genomics platform has attracted another Big Pharma suitor in Merck & Co.

Fraiser Kansteiner Mar 24, 2026 6:00am

Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together

Tenacia pens $308M Rapport deal for China rights to epilepsy med

Mar 9, 2026 10:30am

Formation Bio makes $605M play for Lynk's TYK2 inhibitor

Dec 10, 2025 10:27am

Lilly pens $1.2B pact with Sanegene to target metabolic RNA meds

Nov 10, 2025 4:05am

Compressor inhaler with childs mask and pocket device for asthmatics on background of table

Roche pens $1B deal for respiratory bispecific from China

Oct 30, 2025 5:04am

Kite puts $1.64B on the line for Pregene's in vivo CAR-Ts

Oct 16, 2025 4:56pm